drugset / Trial / NCT01523379

Efficacy of Parecoxib on Patients With CRPS

NCT01523379

Expanded access No longer available Ruhr University of Bochum

Summary

The complex regional pain syndrom is a weighty disease that often results in a lifelong disability. Mostly this disease appears unilateral after comparatively mundane fractures or operations. In early stages CRPS shows inflammatory processes. These inflammatory components can be seen as edema and vasodilatation. These inflammatory processes lead us to the hypothesis that selective COX-2-inhibitors might help patients with CRPS.

Timeline

Start
Primary completion
Completion

Drugs

EvaluationDrugModalityDoseRoute
Subject Parecoxib Small molecule 90 mg Intravenous